Austco Healthcare Ltd · ASX:AHC
Austco Healthcare — Investor Presentation (September 2020)
23 slides from Austco Healthcare's investor presentation, Sep 9, 2020
Slide 1: Investor Presentation
Investor Azure Healthcare Limited Presentation September 2020 Clayton Astles Brendan Maher 1 CEO CFO
Slide 2: Agenda
Agenda Azure Healthcare Limited 1 Market and Products 2 Financial Performance 3 Strategic Objectives 4 Appendices 2
Slide 3: Market & Products
3 Azure Healthcare Limited Market & Products
Slide 4: Global Market
Global Market 2,800 2,666 Strong global demand and the ongoing pressure for efficiencies in health budgets will underpin the 3% 2,100 11. growth of sophisticated nurse call work flow Azure Healthcare Limited solutions. The market for nurse call systems is expected to more than double between 2017 an
Slide 5: Flagship Product: Tacera
Flagship Product: Tacera Tacera is the most advanced IP-based nurse call system in the world, with its fully customisable platform able to cater to facility needs as well as individual patient needs. Azure Healthcare Limited Core Nurse Call System Enhanced Workflow Annunciation, Census Boards Tacera
Slide 6: Tacera: Enable caregiver mobility
Tacera Enable caregiver mobility Azure Healthcare Limited There is increasing interest in this software solution, as facilities attempt to replace expensive, purpose-built mobile devices. Workflow Alarm Management Remote control the nurse call system Prioritised list of assigned alarms Lights the li
Slide 7: Tacera: Built-in RTLS
Tacera Built-in RTLS Azure Healthcare Limited Real-time location has become a critical component to facilities due to its actionable data and efficiencies gained through automation. Uses existing nurse call infrastructure for a cost- effective solution Data and events drive automated processes Robus
Slide 8: Product roadmap
Product roadmap Azure Healthcare Limited Expand mobile capabilities Expand Built-in RTLS and automated workflow Build towards a unified communications platform Explore new technologies Voice control Wearables 8
Slide 9: Financial Performance
9 Azure Healthcare Limited Financial Performance
Slide 10: Revenue Model
Revenue Model Equipment • One off sales with margins between 20% and 60% • Long shelf life which affects resales (up to 15 years) • Heavily weighted to the front end of the contract life Software Installation Azure Healthcare Limited • Sales cycle is 12 to 24 months, additionally new builds can add
Slide 11: Revenue
Revenue Total Revenue in FY20 was up 3.9% in FY20 to $33.0m, including $1.4m of grant income from COVID-19 stimulus packages. Revenue from customers was slightly down in FY20 from COVID-19 impacts: 1,439 89 Azure Healthcare Limited • 1H20 revenue from customers were up 12% on the 31,697 31,598 previ
Slide 12: Gross Profit + Margin
Gross Profit + Margin 52.7% Gross margin % improvement throughout FY20 to average 51.4% 52.0% across the year demonstrates improved supply chain and manufacturing: 47.2% • 1H20 supply chain challenges and tariff issues worked 8,630 Azure Healthcare Limited through to give rise to a 51.4% gross margi
Slide 13: Earnings
Earnings Profits demonstrate growth over the last four halves: Reported NPBT • 2H20 NPBT of $1.7m was assisted by grant income in the period, but was impacted by revenue deferrals arising from COVID-19 restrictions 1,702 Azure Healthcare Limited • 1H20 NPBT of $0.9m demonstrates improvement on prior
Slide 14: Cash + Debt
Cash + Debt • Cash on hand remains strong at $6.4m 6,447 6,061 • The majority of the proceeds of the recent $3.5m capital raising have not yet been deployed in the proposed Sales Azure Healthcare Limited and Marketing initiatives given the interruptions caused by COVID-19, although during calendar 2
Slide 15: Impact of COVID-19
COVID-19 Impact of COVID-19 Production Access to sites • The majority of our Chinese suppliers have returned to full production • Government imposed COVID-19 restrictions in many countries capacity; albeit, with increased safety measures that have impacted continue to have an impact on the Company.
Slide 16: Strategic Objectives
16 Azure Healthcare Limited Strategic Objectives
Slide 17: FY21 Strategic Plan
FY21 Strategic Plan FY20 strategic objectives were met despite COVID-19, underpinning the improved business returns OBJECTIVE STRATEGY Outsource high volume manufacturing to contract manufacturers Improve margins Increase software and SMA sales revenue Recruit sales professionals in strategic locati
Slide 18: Outlook
Outlook Revitalised operating platform Azure Healthcare Limited Market-leading products through sustained R&D commitment COVID uncertainties exist, offset by high level of Order Book Rapidly growing global marketplace, expected to grow even larger post COVID Investment in Sales and Marketing resourc
Slide 19: Appendices
19 Azure Healthcare Limited Appendices
Slide 20: Azure Global Presence
Azure Global Presence Regional offices give a local sales presence to pursue Azure Healthcare Limited opportunities in sophisticated and high value markets USA/Canada United Kingdom Singapore Australia / NZ USA, Canada, Australia, New MARKETS MARKETS UK, Europe MARKETS Asia, Middle East MARKETS Lata
Slide 21: Azure Dashboard
Azure Dashboard Market Information* Share Price Movement (12 months) Share Register 2% Shares on Issue 284,188,951 22% Options on Issue 11.5M Market Cap $21.31M 52-Wk High $0.125 52-Wk Low $0.048 76% Current Share Price $0.075 Board and Management Institutional Shareholders Retail Shareholders Finan
Slide 22: Disclaimer
Disclaimer This presentation was prepared by Azure Healthcare Limited and was Disclaimer authorised for release by the Board of the Company. Other than to the extent required by law, neither Azure nor any of their respective affiliates, associates, shareholders, directors, officers, employees, agent
Slide 23: Azure Healthcare Limited
Azure Healthcare Limited Clayton Astles CEO & Executive Director Telephone Aust: +61 411 531 170 Telephone US: +1 416 565 7457 Email: clayton.astles@austco.com Brendan Maher CFO & Company Secretary Telephone: +61 439 369 551 Email: brendan.maher@austco.com 23
Austco Healthcare — Investor Presentation (September 2020) on 6ix